172 related articles for article (PubMed ID: 27214381)
1. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.
Kweon SM; Chi F; Higashiyama R; Lai K; Tsukamoto H
PLoS One; 2016; 11(5):e0156111. PubMed ID: 27214381
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
3. Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling.
Hasan HF; Abdel-Rafei MK; Galal SM
Biochem Cell Biol; 2017 Jun; 95(3):400-414. PubMed ID: 28177765
[TBL] [Abstract][Full Text] [Related]
4. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
[TBL] [Abstract][Full Text] [Related]
5. The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.
Zhu NL; Wang J; Tsukamoto H
J Biol Chem; 2010 Oct; 285(40):30463-71. PubMed ID: 20663865
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
Huang YH; Kuo HC; Yang YL; Wang FS
Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.
Mann J; Chu DC; Maxwell A; Oakley F; Zhu NL; Tsukamoto H; Mann DA
Gastroenterology; 2010 Feb; 138(2):705-14, 714.e1-4. PubMed ID: 19843474
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
Zhu NL; Asahina K; Wang J; Ueno A; Lazaro R; Miyaoka Y; Miyajima A; Tsukamoto H
J Biol Chem; 2012 Mar; 287(13):10355-10367. PubMed ID: 22298767
[TBL] [Abstract][Full Text] [Related]
9. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
[TBL] [Abstract][Full Text] [Related]
10. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect.
Yang MD; Chiang YM; Higashiyama R; Asahina K; Mann DA; Mann J; Wang CC; Tsukamoto H
Hepatology; 2012 Apr; 55(4):1271-81. PubMed ID: 22095555
[TBL] [Abstract][Full Text] [Related]
11. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway.
Zhou G; Li C; Zhan Y; Zhang R; Lv B; Geng W; Zheng J
Phytomedicine; 2020 Dec; 79():153321. PubMed ID: 32919323
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
15. DNMT1 activates the canonical Wnt signaling in rheumatoid arthritis model rats via a crucial functional crosstalk between miR-152 and the DNMT1, MeCP2.
Miao CG; Qin D; Du CL; Ye H; Shi WJ; Xiong YY; Zhang XL; Yu H; Dou JF; Ma ST; Qin MS; Liu HZ; Fang YX; Zhou GL; Chen JZ; He X; Huang C; Huang Y; Zhang B; Song TW; Li J
Int Immunopharmacol; 2015 Sep; 28(1):344-53. PubMed ID: 26093272
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis.
Yang JJ; Tao H; Huang C; Shi KH; Ma TT; Bian EB; Zhang L; Liu LP; Hu W; Lv XW; Li J
Cell Signal; 2013 May; 25(5):1202-11. PubMed ID: 23333245
[TBL] [Abstract][Full Text] [Related]
17. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
18. Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation.
Tsukamoto H; She H; Hazra S; Cheng J; Miyahara T
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S102-5. PubMed ID: 16958658
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.
Yang JJ; Liu LP; Tao H; Hu W; Shi P; Deng ZY; Li J
Toxicology; 2016 Jun; 359-360():39-46. PubMed ID: 27350269
[TBL] [Abstract][Full Text] [Related]
20. GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation.
Zhou Q; Guan W; Qiao H; Cheng Y; Li Z; Zhai X; Zhou Y
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2367-77. PubMed ID: 25305367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]